Increased neurotoxicity of high‐density lipoprotein secreted from murine reactive astrocytes deficient in a peroxisomal very‐long‐chain fatty acid transporter <scp><i>Abcd1</i></scp>

  • Naoki Fujitani
    Sohyaku, Innovative Research Division Research Unit/Neuroscience, Mitsubishi Tanabe Pharma Corporation Yokohama‐shi Kanagawa Japan
  • Masayoshi Saito
    Sohyaku, Innovative Research Division, DMPK Research Laboratories (Drug Metabolism and Pharmacokinetics), Mitsubishi Tanabe Pharma Corporation Yokohama‐shi Kanagawa Japan
  • Tomoya Akashi
    Sohyaku, Innovative Research Division, DMPK Research Laboratories (Drug Metabolism and Pharmacokinetics), Mitsubishi Tanabe Pharma Corporation Yokohama‐shi Kanagawa Japan
  • Takanori So
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Toyama Japan
  • Kozo Oka
    Sohyaku, Innovative Research Division Research Unit/Neuroscience, Mitsubishi Tanabe Pharma Corporation Yokohama‐shi Kanagawa Japan
  • Masashi Morita
    Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama Toyama Japan

書誌事項

公開日
2023-12-25
資源種別
journal article
権利情報
  • http://onlinelibrary.wiley.com/termsAndConditions#vor
DOI
  • 10.1002/jimd.12703
公開者
Wiley

この論文をさがす

説明

<jats:title>Abstract</jats:title><jats:p>X‐linked adrenoleukodystrophy (X‐ALD) is a genetic neurodegenerative disorder caused by pathogenic variants in <jats:italic>ABCD1</jats:italic>, resulting in the accumulation of very‐long‐chain fatty acids (VLCFAs) in tissues. The etiology of X‐ALD is unclear. Activated astrocytes play a pathological role in X‐ALD. Recently, reactive astrocytes have been shown to induce neuronal cell death via saturated lipids in high‐density lipoprotein (HDL), although how HDL from reactive astrocytes exhibits neurotoxic effects has yet to be determined. In this study, we obtained astrocytes from wild‐type and <jats:italic>Abcd1</jats:italic>‐deficient mice. HDL was purified from the culture supernatant of astrocytes, and the effect of HDL on neurons was evaluated in vitro. To our knowledge, this study shows for the first time that HDL obtained from <jats:italic>Abcd1‐</jats:italic>deficient reactive astrocytes induces a significantly higher level of lactate dehydrogenase (LDH) release, a marker of cell damage, from mouse primary cortical neurons as compared to HDL from wild‐type reactive astrocytes. Notably, HDL from <jats:italic>Abcd1‐</jats:italic>deficient astrocytes contained significantly high amounts of VLCFA‐containing phosphatidylcholine (PC) and LysoPC. Activation of <jats:italic>Abcd1‐</jats:italic>deficient astrocytes led to the production of HDL containing decreased amounts of PC with arachidonic acid in <jats:italic>sn</jats:italic>‐2 acyl moieties and increased amounts of LysoPC, presumably through cytosolic phospholipase A<jats:sub>2</jats:sub>α upregulation. These results suggest that compositional changes in PC and LysoPC in HDL, due to <jats:italic>Abcd1</jats:italic> deficiency and astrocyte activation, may contribute to neuronal damage. Our findings provide novel insights into central nervous system pathology in X‐ALD.</jats:p>

収録刊行物

参考文献 (41)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ